野村ホールディングス株式会社- Post
The share button for X (formerly Twitter) is not available on the current browser you are using.
PDF (183KB)
At the "Cancer Ally Award 2024", the highest ranks of "Diamond", "Gold", and "Silver" were awarded.
December 13, 2024
Nomura Holdings Inc.
Nomura Holdings Inc. (Representative Executive Officer, Group CEO: Kentaro Okuda, hereinafter referred to as "the Company") is working on supporting the treatment of diseases such as cancer and balancing work as part of its health management.
Recently, the seven companies of the Nomura Group received the highest award "Diamond," as well as "Gold" and "Silver," at the "Cancer Ally Award 2024" hosted by the private project "Cancer Ally Group" to realize workplaces and society where cancer patients can work vibrantly while receiving treatment.
Awarded Nomura Group companies
Nomura Securities Co., Ltd. (first award)
Nomura Asset Management Co., Ltd. (three consecutive years)
Nomura Trust Bank Co., Ltd. (First award)
Nomura Business Services Co., Ltd. (Fourth consecutive year)
Nomura Properties Co., Ltd. (Fourth consecutive year)
Nomura Babcock & Brown Co., Ltd. (Third consecutive year)
Nomura Fiduciary Research & Consulting Co., Ltd. (Second consecutive year)
In addition to the initiatives related to cancer that Nomura Securities has worked on, including 'early detection', 'early treatment', and 'balancing treatment with work', the proactive efforts to expand the network of cancer allies both internally within the Nomura Group companies and externally have been recognized, and thus, the company was able to receive the 'Diamond' award.
Main initiatives of the Nomura Group
- Full funding from the Health Insurance Union and the company for human dock exams, including cancer screening for employees aged 30 and over (cervical cancer screenings for all female employees).
- For employees determined to require further examination through cancer screening, the Health Insurance Union recommends receiving additional diagnostic tests.
- Support is provided through systems such as "secondary examination leave" which can be taken during secondary examinations and "sick leave" which can be taken for up to 50 days during illness.
- Support for balancing treatment and work includes providing a "Guidebook for Balancing Treatment and Work" for employees with illnesses and their supervisors, sharing experiences of employees balancing treatment and work (Kira to NOMURA Life), and hosting discussion sessions with employees currently receiving cancer treatment or who have experienced cancer treatment.
- On the Nomura Holdings website, there is a discussion on cancer treatment and employment featuring Soko Kanou and Miho Suzuki, initiators of the Cancer Ally Group, and our Company Executives ("Never Give Up, Even with Cancer: To Keep Shining").
The Nomura Group shares with all employees the goal of health management, which is for "everyone working at Nomura to not just be healthy but to achieve a state of fulfillment physically, mentally, and socially (Well-being)," and promotes initiatives for health maintenance and enhancement under the Chief Health Officer (CHO). Going forward, the group will actively work on maintaining and improving employees' health as part of its purpose to "challenge the world with the power of the financial capital market and realize a prosperous society."
For more information on the Nomura Group's health management initiatives, please refer to our company website.
